Amoxicillin trihydrate compacted

Centrient Pharmaceuticals provides wide range of drug products which includes amoxicillin + clavulanic acid. Dosage form: film-coated tablets; oral suspension; sachets; injectables. Contact us for more information.

Amoxicillin

Centrient Pharmaceuticals provides wide range of drug products which includes atorvastatin. Dosage form: film-coated tablets. Contact us for more information.

Amoxicillin + Clavulanic acid

Centrient Pharmaceuticals provides wide range of drug products which includes rosuvastatin. Dosage form: film-coated tablets. Contact us for more information.

Centrient Pharmaceuticals provides wide range of intermediates which includes 6-amino-penicillanic acid (6-apa). Characteristics: a crystalline powder manufactured by an enzymatic process starting from penicillin g potassium. Application: the product is used as an intermediate for the manufacture of s...

Centrient Pharmaceuticals provides wide range of intermediates which includes 7-aminodeacetoxy-cephalosporanic acid (7-adca). Characteristics: a crystalline powder manufactured via a solvent free green route starting with fermentation followed by an enzymatic strep after which standard downstream processin...

Amoxicillin trihydrate powder

Centrient Pharmaceuticals provides wide range of semi-synthetic penicillins which includes amoxicillin trihydrate compacted. Contact us for more information.

Ampicillin anhydrous compacted

Centrient Pharmaceuticals provides wide range of semi-synthetic penicillins which includes amoxicillin trihydrate powder. Contact us for more information.

Ampicillin anhydrous powder

Centrient Pharmaceuticals (“Centrient”), the business-to-business leader in sustainable, enzymatic antibiotics, next-generation statins and anti-fungals, today announced the completion of the acquisition of Astral SteriTech Private Limited (“Astral SteriTech”).

With the addition of Astral SteriTech’s Semi-Synthetic Cephalosporin and Semi-Synthetic Penicillin sterile injectable finished dosage forms to Centrient’s product portfolio, the company can now further meet the needs of customers and reach more patients with its critical life-saving medicine.

Available Marketing Authorizations